13D Filing: James E. Flynn and Alpine Immune Sciences Inc. (ALPN)

Page 12 of 15

Page 12 of 15 – SEC Filing

(2) Deerfield Management
Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  936,175
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  936,175
(3) Deerfield Special Situations Fund
Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  281,184
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  281,184
 (4) Deerfield Private Design
Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  100,515
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  100,515
(5) Deerfield Private Design International
Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  161,788
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  161,788
(6) Deerfield Private Design II
Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  181,560
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  181,560
(7) Deerfield Private Design International II
Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  208,053
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  208,053
(8) Flynn
Sole power to vote or direct the vote:  0
Shared power to vote or direct the vote:  936,175
Sole power to dispose or to direct the disposition:  0
Shared power to dispose or direct the disposition:  936,175

Follow Alpine Immune Sciences Inc. (NASDAQ:ALPN)

Page 12 of 15